Zobrazeno 1 - 10
of 69
pro vyhledávání: '"V V, Klimontov"'
Publikováno v:
Сахарный диабет, Vol 27, Iss 3, Pp 214-223 (2024)
BACKGROUND: Increased glucose variability is recognized as a risk factor for vascular diabetic complications. It is assumed that deteriorating effect of GV on blood vessels can be realized through the activation of inflammatory signaling pathways.AIM
Externí odkaz:
https://doaj.org/article/110fcc2539d14c378228bfdac332200a
Autor:
V. V. Klimontov, К. R. Mavlianov
Publikováno v:
Сибирский научный медицинский журнал, Vol 44, Iss 2, Pp 19-27 (2024)
Classical knowledge about the pathogenesis of diabetes and its complications in recent years has been supplemented by ideas about the role of chronic inflammation. It has been established that inflammatory reactions play a role in the beta cell dysfu
Externí odkaz:
https://doaj.org/article/2fb916fd9cbe4de38f4640a189a12e3a
Publikováno v:
Сахарный диабет, Vol 27, Iss 1, Pp 25-32 (2024)
BACKGROUND: The diagnosis of liver fibrosis is an important task in the management of patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. The currently used diagnostic methods have a number of disadvantages such as invasivene
Externí odkaz:
https://doaj.org/article/dd12eba49015482bb43f84a744914ab2
Publikováno v:
Сибирский научный медицинский журнал, Vol 43, Iss 6, Pp 148-154 (2024)
Aim of the study was to estimate the blood serum level of microtubule-associated protein 1 light chain 3 alpha (MAP1LC3alpha), beclin-1 (BECN-1), Bcl-2 (BCL-2), caspase-3 (CASP3) and autophagy related 5 (ATG-5) protein as potential markers of liver f
Externí odkaz:
https://doaj.org/article/c0d28537e76e4fe89468901e27fd393c
Autor:
V. V. Klimontov, K. S. Shishin
Publikováno v:
Сахарный диабет, Vol 26, Iss 6, Pp 615-618 (2023)
Open source closed loop automated insulin delivery (CL-AID) systems are increasingly used in the treatment of diabetes. Not being officially approved, such systems are used by patients on their own initiative. Accordingly, the medical community has v
Externí odkaz:
https://doaj.org/article/85790444a76648799b3c58716fb65a93
Autor:
M. V. Shestakova, V. A. Dobronravov, A. S. Ametov, M. B. Antsiferov, M. M. Batyushin, I. N. Bobkova, G. R. Galstyan, T. Y. Demidova, V. V. Klimontov, A. M. Mkrtumyan, N. A. Petunina, E. I. Prokopenko, N. V. Chebotareva, M. S. Shamkhalova
Publikováno v:
Сахарный диабет, Vol 26, Iss 5, Pp 492-499 (2023)
Chronic kidney disease (CKD) in patients with type 2 diabetes (T2D) is one of the most important medical and social problems associated with significant risks for patients and a burden on the national healthcare system. There are significant unmet di
Externí odkaz:
https://doaj.org/article/cd40d33465dc4112b3b1b1597d367b81
Autor:
K. S. Shishin, V. V. Klimontov
Publikováno v:
Сахарный диабет, Vol 26, Iss 4, Pp 352-362 (2023)
Open source closed loop automated insulin delivery (CL-AID) systems are increasingly used in the treatment of diabetes. Assembled on a do-it-yourself (DIY) basis, these systems integrate insulin pumps, continuous glucose monitoring devices, and algor
Externí odkaz:
https://doaj.org/article/0f4f13f51e534c7daa85d5fa7b1d4f05
Publikováno v:
Сахарный диабет, Vol 26, Iss 2, Pp 172-181 (2023)
BACKGROUND: Carotid atherosclerosis (CA) and lower extremity peripheral artery disease (PAD) is a common and potentially life-threatening comorbidity in diabetes.AIM: to determine risk factors and biomarkers of the association of CA and PAD in patien
Externí odkaz:
https://doaj.org/article/845c5561c4c342a3bda937dc01c8ef47
Autor:
V. V. Klimontov
Publikováno v:
Сахарный диабет, Vol 25, Iss 6, Pp 556-563 (2023)
Basal insulin (BI) is the main therapeutic option for patients with type 2 diabetes (T2D) who have not reached glycemic targets on oral antidiabetic drugs and/or glucagon-like peptide-1 receptor agonists. The results of epidemiological studies indica
Externí odkaz:
https://doaj.org/article/3b3aff7738154b278b138e84680904ee
Publikováno v:
Сахарный диабет, Vol 25, Iss 4, Pp 347-357 (2022)
BACKGROUND: High glucose variability (GV) is recognized as a risk factor for vascular diabetic complications and hypoglycemia. Factors affecting GV in patients with diabetes needed to be clarified.AIM: To determine the factors associated with high GV
Externí odkaz:
https://doaj.org/article/00a71eb0031c47b68579e39ca897d322